Company News
Foxtons profits drop amid ‘challenging’ sales market
London estate agent Foxtons posted a decline in full-year pre-tax profits on Tuesday amid "challenging" conditions in the sales market.
Fresnillo delivers 'sound' 2023 despite profits falling 54%
Shares in Fresnillo gained on Tuesday after the Mexico-focused precious metals miner celebrated a "sound operating performance" in 2023 despite profits dropping by more than a half.
Inchcape details 'excellent' FY23, expects more 'moderate' growth in FY24
Automotive distributor Inchcape detailed an "excellent" annual performance on Tuesday but tempered expectations for future growth.
SIG swings to loss amid 'challenging markets'
Building products distributor SIG was under the cosh on Tuesday after saying it swung to a full-year loss as sales were flat in "challenging markets".
Rotork launches £50m share buyback after strong year
Rotork reported a robust performance in its preliminary results on Tuesday, as well as a promising outlook as it implemented its ‘Growth+’ strategy.
Hiscox hails record profits, announces $150m buyback
Hiscox hailed record full-year pre-tax profit on Tuesday amid record investment income as it announced a $150m share buyback.
Intertek FY profits grow on improved revenues
Laboratory testing group Intertek said on Tuesday that profits had grown in 2023, driven by improved full-year revenues and margins.
Apax Global Alpha net asset value stable at year-end
Apax Global Alpha reported an adjusted net asset value of €1. 29bn at year-end in its 2023 results on Tuesday, down slightly from €1. 30bn at the end of 2022, and translating to an adjusted net asset value per share of €2. 62 or £2. 27.
Hochschild signs option to buy Brazil project from Cerrado Gold
Hochschild Mining said it had signed a deal with Cerrado Gold giving it the option to buy a 100% interest in the latter's Monte Do Carmo project located in the state of Tocantins, Brazil.
GSK's ViiV upbeat on ultra-long-acting HIV treatment study
GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).
IWG cautious but confident on 2024 after record revenues
Hybrid-working office space provider IWG reported a sharp rise in annual profits but held a cautious line on 2024 prospects, despite bringing in record revenues last year.
MaxCyte flags lower 2023 revenue, flat 2024 growth
Cell engineering technology specialist MaxCyte said in an update on Tuesday that it expected total 2023 revenue of between $41. 1m and $41. 3m, down from $44. 3m in 2022.
Travis Perkins mulling French exit as 2023 profits sink
Building merchant Travis Perkins said it is looking at exiting its French operations after seeing group operating profits more than halved in 2023.
Bakkavor sees 2024 profits at upper end as China markets rebound
Prepared food supplier Bakkavor said it expected 2024 adjusted operating profit to be at least in line with upper end of market expectations after posting a strong rise in earnings last year as its markets in China recovered from Covid-19 restrictions.
Greggs makes strong start after delivering tasty 2023 profits
High Street bakery chain Greggs maintained guidance and said it had made a strong start to the current year after delivering a jump in 2023 profits as customers sought out its sausage rolls and doughnuts amid the cost-of-living crisis.
Ashtead paints cautious full-year outlook after Q3 slowdown
Equipment rental firm Ashtead has said that full-year group revenues will expand at the low end of its guidance as a result of the previously disclosed slowdown in North America.